TET2 c.3725A>G ;(p.D1242G)

Variant ID: 4-106164857-A-G

NM_001127208.2(TET2):c.3725A>G;(p.D1242G)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.

Bmc Cancer
Williams, Mark S MS; Basma, Naseer J NJ; Amaral, Fabio M R FMR; Wiseman, Daniel H DH; Somervaille, Tim C P TCP
Publication Date: 2021-10-28

Variant appearance in text: TET2: D1242G
PubMed Link: 34711181
Variant Present in the following documents:
  • Main text
  • 12885_2021_8839_MOESM2_ESM.xlsx, sheet 1
  • 12885_2021_Article_8839.pdf
View BVdb publication page